$SEAT

Vivid Seats (SEAT) Q2 2026 Earnings Call Transcript

Vivid Seats (SEAT) reported Q2 2026 results on an earnings call. Marketplace GOV rose to $659.4 million, revenue to $129.9 million, and adjusted EBITDA to $12.6 million, helped by FIFA World Cup demand. The company revised FY2026 GOV guidance to $2.3-$2.6 billion and adjusted EBITDA to $34-$40 million, and renewed its revolving credit facility.

Original reporting
Published Aug 11, 2026, 6:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 11, 2026, 6:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Vivid Seats (SEAT) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$SEATBullishMed
01

Why it matters

The key trading takeaway is the combination of stronger-than-expected Q2 performance and an upward revision to FY2026 Marketplace GOV guidance, alongside a narrowed adjusted EBITDA range. Management attributes strength largely to FIFA World Cup demand and highlights operational execution (including a high fulfillment rate for World Cup orders).

02

Market read

Traders can update models for FY2026 GOV and adjusted EBITDA based on the raised guidance and narrowed range, while monitoring take-rate softness and cancellation impacts.

03

What to watch

The quarter included $16.4M negative impact from event cancellations; traders may want to stress-test GOV and EBITDA sensitivity to cancellation risk and pricing pressure from marquee events.

Relevance 9/10Novelty 8/10Timing: post-earnings, guidance update for FY2026

Background

The article is a Q2 2026 earnings call transcript for Vivid Seats, focusing on Marketplace GOV, revenue, adjusted EBITDA, and updated FY2026 guidance.

Company-level read

Ticker impact

$SEATBullishMedium confidence
Context

Vivid Seats reported Q2 2026 Marketplace GOV of $659.4M and raised FY2026 GOV guidance to $2.3B to $2.6B.

Expected impact

Moderately positive bias for the next few sessions as traders reprice FY2026 GOV and adjusted EBITDA expectations.

Evidence & confidence

The article discloses multiple fresh, decision-relevant datapoints: Q2 results, upward GOV guidance, narrowed adjusted EBITDA guidance, and a renewed revolver extending maturity through Aug 2029.

Market effects

Reinforces that ticket marketplaces can monetize major global events with measurable GOV and take-rate dynamics, potentially affecting sentiment across online ticketing/resale platforms.

Limited direct regional read-through; World Cup demand is global but execution details may influence investor views on operational resilience.

World Cup contribution and 2028 Olympics catalyst highlight event-cycle exposure as a recurring driver for the sector’s growth narrative.

Counterpoint

Despite the guidance raise, resale orders fell year over year and take rate slipped, suggesting margin pressure could reappear after the event cycle fades.

Key entities

  • Vivid Seats

    Reported Q2 2026 Marketplace GOV, revenue, adjusted EBITDA, and revised upward FY2026 guidance.

  • Larry Fey

    CEO who attributed Q2 strength to World Cup demand and discussed competitive moderation and pricing dynamics.

  • Joe Thomas

    CFO who supported the financial metrics and guidance updates discussed on the call.

Related articles

$SEATHighAI 9/10

Why is StubHub stock collapsing today?

StubHub shares fell about 18.5% in pre-open trading to $6.96 after its Q2 2026 earnings showed adjusted EPS near $0.00 versus $0.24 expected. Revenue rose to a record $573.1 million (+33% YoY) and gross merchandise sales to $3.1 billion (+34%). BofA downgraded to Underperform and cut its price target to $7.50 from $11.00.

$LYVMed

Ontario Ticket Resale Cap Enters Enforcement Phase as Critics’ Warnings Start to Materialize

Ontario’s ticket resale price cap, passed in the 2026 budget, is entering an enforcement phase. The province says 32 staff are assigned to resale enforcement and more will be redeployed ahead of the 2026 FIFA World Cup in Toronto. The cap bars resale above original purchase price, with fines of $3,000 to $250,000. Ontario has sent inspection letters to StubHub and SeatGeek, while Ticketmaster introduced temporary pricing limits and waived seller fees.

$WCNMedAI 8/10

WCN Q3 deep dive: margin expansion and sustainability initiatives drive optimism for 2027

Waste Connections (WCN) reported Q3 revenue of $2.64B, beating estimates by 1.2%, and adjusted EPS of $1.58, beating by 3.9%. The company raised its full-year revenue guidance to $10.09B. Operating margin expanded to 20.5% from 17.9% YoY. Management highlighted margin expansion from pricing discipline, landfill volume recovery, and sustainability investments, including RNG facilities. The board approved a 10% dividend increase and $1B in share repurchases.

$BEMedAI 8/10

Another AI power stock plunges 11% despite earnings beat

Bloom Energy (BE) shares fell 11% on Oct. 23 despite beating Q3 earnings estimates and raising its 2026 outlook. The company reported adjusted earnings of $0.94 per share and revenue of $1.24 billion, both above expectations. However, negative free cash flow and broader market sentiment weighed on the stock. Analysts remain divided on price targets, with JPMorgan lowering its target to $292 and Morgan Stanley raising it to $335.

$CACIHighAI 9/10

CACI Q3 deep dive: margins rise on technology mix, modest revenue miss offsets robust contract wins

CACI reported Q3 revenue of $2.47B, missing estimates by 1.4%, but beat EPS and EBITDA expectations. The company raised full-year revenue and EPS guidance. Margins improved due to higher-margin technology contracts, and backlog remained steady at $34B. Growth was driven by defense and space contracts, with new manufacturing centers supporting future production.

$MEDPMedAI 8/10

MEDP Q3 deep dive: bookings strength drives growth, margin expansion continues

MEDP reported Q3 revenue of $716M, beating estimates, with EPS of $4.84 and adjusted EBITDA of $172.1M. The company reconfirmed full-year revenue guidance of $2.85B and raised EPS guidance to $18.15. Growth was driven by strong bookings in oncology research and margin expansion from a favorable project mix. Management highlighted stable competition, low turnover, and sustained bookings momentum, but noted project cancellations as a watchpoint.